Freshfields advised Novartis on its exclusive license agreement with Arvinas for a potential first-in-class prostate cancer treatment. Novartis, a global healthcare company, has entered into an...
Novartis’ Licensing Agreement with Arvinas
Merz Therapeutics’ $185m Acquisition of Acorda Therapeutics
Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...